BiotechTube
Home/Atommap/Mandana Honu, PhD
MH

Mandana Honu, PhD

Head of Business Development

Atommap

Therapeutic Areas

Oncology

Atommap Pipeline

DrugIndicationPhase
Mutant KRAS ProgramOncology (KRAS-mutant cancers)Pre-clinical
SMARCA2 Degrader ProgramOncologyPre-clinical
Mutant-Selective Degrader ProgramOncology (unspecified mutant oncoprotein)Pre-clinical

Leadership Team at Atommap

HX
Huafeng Xu, PhD
Founder and CEO
JI
Jesus Izaguirre, PhD
Co-founder and Chief Computational Scientist
YW
Yujie Wu, PhD
Co-founder and Chief Technology Officer
CK
Cheryl Koh, PhD
Head of Discovery Biology
AZ
Arie Zask, PhD
Head of Chemistry
View full Atommap profile